PL3046933T3 - Analogi kortystatyny do leczenia chorób zapalnych i/lub immunologicznych - Google Patents
Analogi kortystatyny do leczenia chorób zapalnych i/lub immunologicznychInfo
- Publication number
- PL3046933T3 PL3046933T3 PL14766508T PL14766508T PL3046933T3 PL 3046933 T3 PL3046933 T3 PL 3046933T3 PL 14766508 T PL14766508 T PL 14766508T PL 14766508 T PL14766508 T PL 14766508T PL 3046933 T3 PL3046933 T3 PL 3046933T3
- Authority
- PL
- Poland
- Prior art keywords
- inflammatory
- treatment
- immune diseases
- cortistatin analogues
- cortistatin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Birds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382361 | 2013-09-18 | ||
| PCT/EP2014/069842 WO2015040089A1 (en) | 2013-09-18 | 2014-09-17 | Co rti statin analogues for the treatment of inflammatory and/or immune diseases |
| EP14766508.7A EP3046933B1 (en) | 2013-09-18 | 2014-09-17 | Cortistatin analogues for the treatment of inflammatory and/or immune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3046933T3 true PL3046933T3 (pl) | 2019-08-30 |
Family
ID=49880656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14766508T PL3046933T3 (pl) | 2013-09-18 | 2014-09-17 | Analogi kortystatyny do leczenia chorób zapalnych i/lub immunologicznych |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US12297294B2 (enExample) |
| EP (1) | EP3046933B1 (enExample) |
| JP (1) | JP6989260B2 (enExample) |
| KR (1) | KR102285939B1 (enExample) |
| CN (1) | CN105579467B (enExample) |
| AU (1) | AU2014323131B2 (enExample) |
| BR (1) | BR112016005731B1 (enExample) |
| CA (1) | CA2921324C (enExample) |
| CL (1) | CL2016000392A1 (enExample) |
| DK (1) | DK3046933T3 (enExample) |
| ES (1) | ES2728319T3 (enExample) |
| HU (1) | HUE043206T2 (enExample) |
| IL (1) | IL244317B (enExample) |
| LT (1) | LT3046933T (enExample) |
| MX (1) | MX368373B (enExample) |
| MY (1) | MY185593A (enExample) |
| NZ (1) | NZ717035A (enExample) |
| PL (1) | PL3046933T3 (enExample) |
| PT (1) | PT3046933T (enExample) |
| RU (1) | RU2678315C2 (enExample) |
| SG (1) | SG11201601036UA (enExample) |
| UA (1) | UA119148C2 (enExample) |
| WO (1) | WO2015040089A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015100420A1 (en) | 2013-12-24 | 2015-07-02 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
| EP3294298A4 (en) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
| WO2017004411A1 (en) * | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
| JP2020526515A (ja) | 2017-07-05 | 2020-08-31 | ウィスコンシン・アルムナイ・リサーチ・ファウンデーションＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 遺伝子送達成果を改善する核酸と抗炎症性分子の共送達のためのミネラルコーティングされたマイクロ粒子 |
| US12161748B2 (en) | 2018-01-31 | 2024-12-10 | Twi Biotechnology, Inc. | Topical formulations comprising tofacitinib |
| JP7324210B2 (ja) * | 2018-01-31 | 2023-08-09 | ティダブリューアイ・バイオテクノロジー・インコーポレイテッド | トファシチニブを含む局所製剤 |
| EP3774848B1 (en) | 2018-03-29 | 2023-02-22 | Lateral Ip Pty Ltd | Cyclic peptides and uses thereof |
| RU2698451C1 (ru) * | 2018-07-02 | 2019-08-27 | Павел Александрович Храмов | Средство и способ для лечения нейросенсорной тугоухости |
| ES2780274A1 (es) * | 2019-02-15 | 2020-08-24 | Consejo Superior De Investig Científicas (Csic) | Cortistatina o un análogo de la misma como agente farmacéuticamente activo en forma latente |
| AU2020397424B2 (en) * | 2019-12-05 | 2025-12-04 | Bcn Peptides, S.A. | Peptides for the treatment of cancer and/or metastasis |
| CN111297876B (zh) * | 2020-01-16 | 2021-04-27 | 武汉理工大学 | 一种塞来昔布胶束和和厚朴酚胶束药物联用控释系统及其制备方法 |
| CN115120702A (zh) * | 2020-03-30 | 2022-09-30 | 山东大学齐鲁医院 | 皮质抑素14在制备银屑病治疗药物中的应用 |
| CN113797314B (zh) * | 2021-09-29 | 2023-08-22 | 山东大学齐鲁医院 | Cst多肽在制备股骨头坏死治疗药物中的应用 |
| CN114949174B (zh) * | 2022-07-19 | 2025-09-30 | 山东大学齐鲁医院 | Cst-14在制备糖尿病皮肤溃疡、破损治疗药物中的应用 |
| CN117866953B (zh) * | 2023-03-02 | 2025-03-07 | 江西省人民医院 | 靶向生长激素释放抑制激素基因的shRNA及其医药应用 |
| CN117567554B (zh) * | 2023-11-16 | 2025-03-07 | 中国科学技术大学 | 一种荷载抗炎药的凝胶因子、水凝胶及制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2257108A1 (en) * | 1996-06-07 | 1997-12-11 | Takeda Chemical Industries, Ltd. | Novel peptides and production and use thereof |
| US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| EP1040837A3 (en) | 1999-02-26 | 2002-01-02 | Erasmus Universiteit Rotterdam | Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder |
| WO2007081792A2 (en) | 2006-01-05 | 2007-07-19 | University Of Utah Research Foundation | Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| WO2007082980A1 (es) | 2006-01-23 | 2007-07-26 | Consejo Superior De Investigaciones Científicas | Composiciones y procedimientos para tratar trastornos inflamatorios e inmunitarios con cortistatina |
| WO2009043523A2 (en) | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| EP2168983A1 (fr) | 2008-09-30 | 2010-03-31 | Ipsen Pharma | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
| ES2351569B8 (es) * | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
-
2014
- 2014-09-17 KR KR1020167008345A patent/KR102285939B1/ko active Active
- 2014-09-17 SG SG11201601036UA patent/SG11201601036UA/en unknown
- 2014-09-17 BR BR112016005731-7A patent/BR112016005731B1/pt active IP Right Grant
- 2014-09-17 PL PL14766508T patent/PL3046933T3/pl unknown
- 2014-09-17 MX MX2016003490A patent/MX368373B/es active IP Right Grant
- 2014-09-17 ES ES14766508T patent/ES2728319T3/es active Active
- 2014-09-17 CN CN201480048751.9A patent/CN105579467B/zh active Active
- 2014-09-17 WO PCT/EP2014/069842 patent/WO2015040089A1/en not_active Ceased
- 2014-09-17 US US14/912,343 patent/US12297294B2/en active Active
- 2014-09-17 AU AU2014323131A patent/AU2014323131B2/en active Active
- 2014-09-17 LT LTEP14766508.7T patent/LT3046933T/lt unknown
- 2014-09-17 CA CA2921324A patent/CA2921324C/en active Active
- 2014-09-17 MY MYPI2016000336A patent/MY185593A/en unknown
- 2014-09-17 NZ NZ71703514A patent/NZ717035A/en unknown
- 2014-09-17 RU RU2016109410A patent/RU2678315C2/ru active
- 2014-09-17 UA UAA201601741A patent/UA119148C2/uk unknown
- 2014-09-17 HU HUE14766508A patent/HUE043206T2/hu unknown
- 2014-09-17 DK DK14766508.7T patent/DK3046933T3/da active
- 2014-09-17 EP EP14766508.7A patent/EP3046933B1/en active Active
- 2014-09-17 PT PT14766508T patent/PT3046933T/pt unknown
- 2014-09-17 JP JP2016543392A patent/JP6989260B2/ja active Active
-
2016
- 2016-02-22 CL CL2016000392A patent/CL2016000392A1/es unknown
- 2016-02-28 IL IL244317A patent/IL244317B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273815B (en) | Secondary vaccine particles for the treatment of inflammation | |
| IL244317B (en) | Cortistatin analogs for the treatment of inflammatory and/or immune diseases | |
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| EP2968318A4 (en) | ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES | |
| IL251639A0 (en) | Preparations including ohepa-15 and methods for using them | |
| GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| ZA201603117B (en) | Withanolides useful for the treatment of neurodegenerative diseases | |
| ZA201507718B (en) | The local treatment of inflammatory ophthalmic diseases | |
| EP3089984A4 (en) | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES | |
| PL3079684T3 (pl) | Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna | |
| EP2974726A4 (en) | Agent for the prophylaxis and/or treatment of neoplastic diseases | |
| IL250244B (en) | Prevention and treatment of inflammatory skin diseases | |
| GB201314015D0 (en) | Novel compound useful for the treatment of degenerative and inflammatory diseases | |
| GB201315079D0 (en) | Novel compounds useful for the treatment of degenerative and inflammatory diseases | |
| GB201314016D0 (en) | Novel compounds useful for the treatment of degenerative and inflammatory diseases | |
| GB201306413D0 (en) | The local treatment of ophthalmic diseases | |
| GB201306975D0 (en) | Stents and methods of manufacture | |
| GB201300628D0 (en) | Compositions comprising 15-OHEPA and methods of using the same |